Vanda Pharmaceuticals Inc.
VNDA
$3.92
-$0.06-1.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 340.91M | 374.64M | 376.26M | 387.68M | 394.14M |
| Total Receivables | 44.60M | 47.10M | 42.75M | 41.86M | 36.71M |
| Inventory | 1.92M | 1.73M | 1.61M | 1.47M | 1.51M |
| Prepaid Expenses | 20.48M | 15.42M | 11.76M | 8.17M | 7.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 407.91M | 438.89M | 432.39M | 439.18M | 439.43M |
|
|
|||||
| Total Current Assets | 407.91M | 438.89M | 432.39M | 439.18M | 439.43M |
| Net Property, Plant & Equipment | 12.48M | 12.68M | 8.19M | 8.68M | 9.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 112.34M | 114.10M | 115.85M | 117.60M | 119.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 99.21M | 90.54M | 88.69M | 85.91M | 84.86M |
| Total Assets | 631.94M | 656.20M | 645.12M | 651.37M | 652.68M |
|
|
|||||
| Total Accounts Payable | 5.99M | 3.50M | 5.81M | 2.27M | 4.34M |
| Total Accrued Expenses | 34.90M | 31.32M | 31.04M | 34.91M | 31.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.39M | 4.27M | 2.45M | 2.43M | 2.41M |
| Total Finance Division Other Current Liabilities | 58.64M | 60.90M | 49.79M | 54.19M | 55.57M |
| Total Other Current Liabilities | 58.64M | 60.90M | 49.79M | 54.19M | 55.57M |
| Total Current Liabilities | 103.92M | 99.98M | 89.09M | 93.79M | 93.34M |
|
|
|||||
| Total Current Liabilities | 103.92M | 99.98M | 89.09M | 93.79M | 93.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.35M | 8.09M | 5.49M | 6.01M | 6.51M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.25M | 9.59M | 9.32M | 9.06M | 8.83M |
| Total Liabilities | 120.52M | 117.66M | 103.89M | 108.86M | 108.69M |
|
|
|||||
| Common Stock & APIC | 714.82M | 712.76M | 709.90M | 706.90M | 703.92M |
| Retained Earnings | -203.79M | -174.29M | -169.38M | -164.06M | -159.54M |
| Treasury Stock & Other | 383.00K | 74.00K | 702.00K | -330.00K | -383.00K |
| Total Common Equity | 511.42M | 538.55M | 541.22M | 542.52M | 544.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 511.42M | 538.55M | 541.22M | 542.52M | 544.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 511.42M | 538.55M | 541.22M | 542.52M | 544.00M |
|
|
|||||